Skip to main content
Top
Published in: Diabetologia 5/2003

01-05-2003 | Observation

The polymorphism Gly574Ser in the transcription factor HNF-1α is not a marker of adult-onset ketosis-prone atypical diabetes in Afro-Caribbean patients

Authors: Dr. F. Mauvais-Jarvis, P. Boudou, E. Sobngwi, J. P. Riveline, J. P. Kevorkian, J. M. Villette, R. Porcher, P. Vexiau, J. F. Gautier

Published in: Diabetologia | Issue 5/2003

Login to get access

Excerpt

To the Editor: Type 1B diabetes or ketosis-prone atypical diabetes (KPAD) is a subtype of diabetes mostly described in patients of sub-Saharan African ancestry and characterized by insulin dependence at the time of presentation, without immunological markers seen in typical Type 1A diabetes (T1D), and frequently followed by absence of insulin requirements as in the case of Type 2 diabetes (T2D) [1, 2, 3]. The subsequent clinical course of KPAD, which could represent up to 12% of the sub-Saharan African diabetic population, is characterized by an alternance of near normoglycaemic remissions and relapses of insulin dependence without precipitating illness [3, 4]. Despite metabolic studies showing a beta-cell insulin secretory defect, no large genetic characterization has focused on this clinical subtype of diabetes. …
Literature
1.
go back to reference Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP (1987) Maturity-onset diabetes of youth in black Americans. N Engl J Med 316:285–291 Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP (1987) Maturity-onset diabetes of youth in black Americans. N Engl J Med 316:285–291
2.
go back to reference Banerji MA, Chaiken RL, Huey H, et al. (1994) GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 43:741–745 Banerji MA, Chaiken RL, Huey H, et al. (1994) GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 43:741–745
3.
go back to reference Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF (2002) Diabetes in Africans. Part 2: Ketosis-prone atypical diabetes mellitus. Diabetes Metab 28:5–12 Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF (2002) Diabetes in Africans. Part 2: Ketosis-prone atypical diabetes mellitus. Diabetes Metab 28:5–12
4.
go back to reference Sobngwi E, Vexiau P, Levy V, et al. (2002) Metabolic and immunogenetic prediction of long term insulin remission in black africans with atypical diabetes. Diabet Med 19:832–835CrossRefPubMed Sobngwi E, Vexiau P, Levy V, et al. (2002) Metabolic and immunogenetic prediction of long term insulin remission in black africans with atypical diabetes. Diabet Med 19:832–835CrossRefPubMed
5.
go back to reference Yamagata K, Oda N, Kaisaki PJ, et al. (1996). Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384:455–458 Yamagata K, Oda N, Kaisaki PJ, et al. (1996). Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384:455–458
6.
go back to reference Boutin P, Gresh L, Cisse A, et al. (1999) Missense mutation Gly574Ser in the transcription factor HNF-1alpha is a marker of atypical diabetes mellitus in African-American children. Diabetologia 42:380–381 Boutin P, Gresh L, Cisse A, et al. (1999) Missense mutation Gly574Ser in the transcription factor HNF-1alpha is a marker of atypical diabetes mellitus in African-American children. Diabetologia 42:380–381
7.
go back to reference Elbein SC, Teng K, Eddings K, Hargrove D, Scroggin E (2000) Molecular scanning analysis of hepatocyte nuclear factor 1alpha (TCF1) gene in typical familial type 2 diabetes in African Americans. Metabolism 49:280–284PubMed Elbein SC, Teng K, Eddings K, Hargrove D, Scroggin E (2000) Molecular scanning analysis of hepatocyte nuclear factor 1alpha (TCF1) gene in typical familial type 2 diabetes in African Americans. Metabolism 49:280–284PubMed
8.
go back to reference Collet C, Ducorps M, Mayaudon H, et al.(2002). Prevalence of the missense mutation Gly574Ser in the hepatocyte nuclear factor-1alpha in Africans with diabetes. DiabetesMetab 28:39–44 Collet C, Ducorps M, Mayaudon H, et al.(2002). Prevalence of the missense mutation Gly574Ser in the hepatocyte nuclear factor-1alpha in Africans with diabetes. DiabetesMetab 28:39–44
Metadata
Title
The polymorphism Gly574Ser in the transcription factor HNF-1α is not a marker of adult-onset ketosis-prone atypical diabetes in Afro-Caribbean patients
Authors
Dr. F. Mauvais-Jarvis
P. Boudou
E. Sobngwi
J. P. Riveline
J. P. Kevorkian
J. M. Villette
R. Porcher
P. Vexiau
J. F. Gautier
Publication date
01-05-2003
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2003
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1093-9

Other articles of this Issue 5/2003

Diabetologia 5/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.